Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29330483 | 1.00 | APP (0.31) | APPALOX5 | |
| SCHEMBL31114965 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL29330492 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL29725684 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL2624852 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL24632196 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL30067164 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL29403553 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL30673511 | 0.88 | ALOX5 (0.36) | APPALOX5 | |
| SCHEMBL29381348 | 0.88 | ALOX5 (0.36) | APPALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238252-A1 | PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUND SMTP-7 | CORXEL PHARMACEUTICALS HONG KONG LIMITED (CN) | 2024-07-18 | — | — | US | disclosed |
| US-20240238248-A1 | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING CEREBRAL INFARCTION | CORXEL PHARMACEUTICALS HONG KONG LIMITED (CN) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238248-A1 | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING CEREBRAL INFARCTION | PSD, SCN7A, MBOAT7 | APP 1162/4885ALOX5 3129/4885 |
| US-20240238252-A1 | PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUND SMTP-7 | SMPD1, SMPD3, MBOAT7 | APP 695/4885ALOX5 2914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.